Aromatase mRNA expression in individual follicles from polycystic ovaries.

Polycystic ovary syndrome (PCOS) is a common reproductive disorder characterized by arrested follicular development prior to selection of a dominant follicle. Dominant follicles produce large amounts of oestradiol but PCOS follicles do not. With several potential aromatase (P450AROM) inhibitors in follicular fluid, the question arises whether P450AROM is expressed in PCOS granulosa cells, but the activity is inhibited, or whether P450AROM is not expressed in PCOS. The purpose of the present study was to determine whether P450AROM mRNA expression is altered in PCOS and to correlate P450AROM mRNA expression in individual follicles with aromatase stimulatory bioactivity and oestradiol in the follicular microenvironments. P450AROM mRNA was measured in individual follicles from 16 PCOS and 48 regularly cycling control women by quantitative polymerase chain reaction (PCR) and correlated with follicular fluid oestradiol concentrations and aromatase stimulating bioactivity measured by the rat granulosa cells aromatase bioassay. Follicular fluid oestradiol was low in all control follicles <7 mm in diameter. Some follicles > or = 7 mm contained elevated oestradiol values (P < 0.01) and all had an androstenedione:oestradiol ratio of <4. Only in granulosa cells from follicles > or = 7 mm with an androstenedione:oestradiol ratio of <4 were P450AROM mRNA levels increased (P < 0.05). These same follicles also contained increased levels of aromatase stimulating bioactivity whereas follicles <7 mm or with androstenedione:oestradiol ratio of >4 contained little or no bioactivity. All PCOS follicles contained low levels of oestradiol, P450AROM mRNA and aromatase stimulating bioactivity similar to size-matched control follicles. These data indicate that P450AROM mRNA expression and oestradiol production begin in developing follicles when they reach approximately 7 mm in diameter. Oestradiol production is low in PCOS follicles because there is insufficient aromatase stimulating bioactivity to increase P450AROM mRNA expression.

[1]  S. Ho,et al.  Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. , 2013, BioTechniques.

[2]  D. Magoffin,et al.  Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. , 1997, Human reproduction.

[3]  S. Agarwal,et al.  A mechanism for the suppression of estrogen production in polycystic ovary syndrome. , 1996, The Journal of clinical endocrinology and metabolism.

[4]  P. Terranova,et al.  Tumour necrosis factor-alpha inhibits follicle-stimulating hormone-induced granulosa cell oestradiol secretion in the human: dependence on size of follicle. , 1996, Human reproduction.

[5]  B. Fauser,et al.  Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles , 1996, Clinical endocrinology.

[6]  N. Ling,et al.  Follistatin concentrations in follicular fluid of normal and polycystic ovaries. , 1995, Human reproduction.

[7]  W. Hop,et al.  Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. , 1995, Fertility and sterility.

[8]  R. Lobo.  A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". what are we to call it?! , 1995, Fertility and sterility.

[9]  H. Mason,et al.  Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. , 1994, The Journal of clinical endocrinology and metabolism.

[10]  L. Reichert,et al.  Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. , 1993, The Journal of clinical endocrinology and metabolism.

[11]  D. Magoffin,et al.  Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. , 1992, The Journal of clinical endocrinology and metabolism.

[12]  W. Hop,et al.  17β‐Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals * , 1992, Clinical endocrinology.

[13]  L. Giudice,et al.  Insulin-like growth factor binding protein profiles in human ovarian follicular fluid correlate with follicular functional status. , 1992, The Journal of clinical endocrinology and metabolism.

[14]  D. Magoffin,et al.  Granulosa cells of polycystic ovaries: are they normal or abnormal? , 1992, Human reproduction.

[15]  R. Sprengel,et al.  Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity , 1991 .

[16]  H. Mason,et al.  INHIBITION OF OESTRADIOL PRODUCTION BY EPIDERMAL GROWTH FACTOR IN HUMAN GRANULOSA CELLS OF NORMAL AND POLYCYSTIC OVARIES , 1990, Clinical endocrinology.

[17]  N. Ling,et al.  An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. , 1989, Endocrinology.

[18]  C. Mendelson,et al.  Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[20]  A. Hsueh,et al.  Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay. , 1986, The Journal of clinical endocrinology and metabolism.

[21]  A. Gougeon.  Dynamics of follicular growth in the human: a model from preliminary results. , 1986, Human reproduction.

[22]  S. Yen,et al.  New Data on Follicle Cells in Polycystic Ovaries: A Proposed Mechanism for the Genesis of Cystic Follicles , 1984 .

[23]  W. Wilfinger,et al.  Fluorometric quantification of DNA in cells and tissue. , 1983, Analytical biochemistry.

[24]  D. Magoffin,et al.  Primary culture of differentiating ovarian androgen-producing cells in defined medium. , 1982, The Journal of biological chemistry.

[25]  E. Milgrom,et al.  Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. , 1981, The Journal of clinical endocrinology and metabolism.

[26]  R. Osathanondh,et al.  The intraovarian sites of androgen and estrogen formation in women with normal and hyperandrogenic ovaries as judged by in vitro experiments. , 1980, The Journal of clinical endocrinology and metabolism.

[27]  S. C. Yen,et al.  REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME , 1980 .

[28]  R. Osathanondh,et al.  The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. , 1979, The Journal of clinical endocrinology and metabolism.

[29]  A. Hsueh,et al.  Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. , 1979, The Journal of clinical endocrinology and metabolism.

[30]  D. Baird,et al.  Relationship between follicle-stimulating hormone, androstenedione and oestradiol in human follicular fluid. , 1978, The Journal of endocrinology.

[31]  W. Hunter,et al.  Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human graafian follicles throughout the menstrual cycle. , 1975, The Journal of endocrinology.

[32]  J. Goldzieher.  Polycystic ovarian disease. , 1973, Clinical obstetrics and gynecology.

[33]  J. Goldzieher,et al.  CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE. , 1963, Fertility and sterility.

[34]  B. Fauser,et al.  Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[35]  H. Mason,et al.  Insulin-like growth factor (IGF) I and II, IGF-binding proteins, and IGF-binding protein proteases are produced by theca and stroma of normal and polycystic human ovaries. , 1996, The Journal of clinical endocrinology and metabolism.

[36]  K. Ryan,et al.  Steroid biosynthesis by human ovarian granulosa and thecal cells. , 1966, The Journal of clinical endocrinology and metabolism.